SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Healthy Extracts Inc. (HYEX) , forward earnings yield 8.12%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 12.3
Overall SharesGrow Score: 22/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HYEX
Valuation Multiples
P/E (TTM)0.0
Forward P/E12.3
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.53
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.28
Forward EPS (Est.)$0.13
Book Value / Share$0.00
Revenue / Share$1.05
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield8.12%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-129.28 |
$115.55K |
$-730.87K |
-632.5% |
| 2016 |
$-537.27 |
$162.75K |
$-3.37M |
-2071.2% |
| 2017 |
$-158.17 |
$128.11K |
$-3.56M |
-2780.6% |
| 2018 |
$-145.40 |
$67.13K |
$-3.33M |
-4959.7% |
| 2019 |
$0.69 |
$748.38K |
$632.78K |
84.6% |
| 2020 |
$-1.34 |
$1.28M |
$-2.65M |
-207.5% |
| 2021 |
$-0.77 |
$1.47M |
$-2.04M |
-139.1% |
| 2022 |
$-0.35 |
$2.25M |
$-989.96K |
-44% |
| 2023 |
$-0.85 |
$2.49M |
$-2.47M |
-99.5% |
| 2024 |
$-0.28 |
$3.11M |
$-840.67K |
-27% |
